231 related articles for article (PubMed ID: 23815946)
1. [Relationship between microRNA-155 and hematological malignancies].
Xue H; Hua LM; Luo JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):810-4. PubMed ID: 23815946
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNAs in normal and malignant hematopoiesis.
Vasilatou D; Papageorgiou S; Pappa V; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2010 Jan; 84(1):1-16. PubMed ID: 19744129
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in hematological malignancies: a novel approach to targeted therapy.
Joshi D; Gosh K; Vundinti BR
Hematology; 2012 May; 17(3):170-5. PubMed ID: 22664117
[TBL] [Abstract][Full Text] [Related]
4. Hematological malignancies: role of miRNAs and their in silico aspects.
Omer A; Yadav NK; Singh P; Singh RK
Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNAs in hematological malignancies.
Fatica A; Bozzoni I
Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
[TBL] [Abstract][Full Text] [Related]
6. Expression Levels of Warburg-Effect Related microRNAs Correlate with each Other and that of Histone Deacetylase Enzymes in Adult Hematological Malignancies with Emphasis on Acute Myeloid Leukemia.
Gaál Z; Oláh É; Rejtő L; Bálint BL; Csernoch L
Pathol Oncol Res; 2017 Jan; 23(1):207-216. PubMed ID: 27864740
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies.
Dzikiewicz-Krawczyk A
Crit Rev Oncol Hematol; 2015 Jan; 93(1):1-17. PubMed ID: 25217091
[TBL] [Abstract][Full Text] [Related]
8. [MicroRNA-s and their role in malignant hematologic diseases].
Gaál Z; Oláh E
Orv Hetil; 2012 Dec; 153(52):2051-9. PubMed ID: 23261993
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs: pivotal regulators in acute myeloid leukemia.
Li M; Cui X; Guan H
Ann Hematol; 2020 Mar; 99(3):399-412. PubMed ID: 31932900
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs: key players of normal and malignant myelopoiesis.
Alemdehy MF; Erkeland SJ
Curr Opin Hematol; 2012 Jul; 19(4):261-7. PubMed ID: 22504525
[TBL] [Abstract][Full Text] [Related]
11. The miR-29 family in hematological malignancies.
Fiserova B; Kubiczkova L; Sedlarikova L; Hajek R; Sevcikova S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):184-91. PubMed ID: 25004911
[TBL] [Abstract][Full Text] [Related]
12. Limited miR-17-92 overexpression drives hematologic malignancies.
Danielson LS; Reavie L; Coussens M; Davalos V; Castillo-Martin M; Guijarro MV; Coffre M; Cordon-Cardo C; Aifantis I; Ibrahim S; Liu C; Koralov SB; Hernando E
Leuk Res; 2015 Mar; 39(3):335-41. PubMed ID: 25597017
[TBL] [Abstract][Full Text] [Related]
13. miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.
Huang W; Paul D; Calin GA; Bayraktar R
Cells; 2023 Dec; 13(1):. PubMed ID: 38201290
[TBL] [Abstract][Full Text] [Related]
14. [Research Progress on miR-125 Family in Malignant Hematologic Diseases-Review].
Liu AF; Wang JX; Li FL; Chen YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1842-1846. PubMed ID: 29262928
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances on application of small RNA in research for hematological malignancies - review].
Li ZJ; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1237-41. PubMed ID: 18928636
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-binding site polymorphisms in hematological malignancies.
Dzikiewicz-Krawczyk A
J Hematol Oncol; 2014 Nov; 7():83. PubMed ID: 25421940
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of the miR-34a in hematological malignancies.
Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
19. MiR-125 in normal and malignant hematopoiesis.
Shaham L; Binder V; Gefen N; Borkhardt A; Izraeli S
Leukemia; 2012 Sep; 26(9):2011-8. PubMed ID: 22456625
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune.
Fatica A; Fazi F
Int J Mol Sci; 2013 Oct; 14(10):20930-53. PubMed ID: 24145746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
